GH Research Plc (GHRS)
18.07
-0.43
(-2.32%)
USD |
NASDAQ |
Oct 23, 16:00
18.10
+0.03
(+0.17%)
After-Hours: 20:00
GH Research Net Income (Quarterly) : -15.15M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -15.15M |
| March 31, 2026 | -18.97M |
| December 31, 2025 | -14.14M |
| September 30, 2025 | -14.02M |
| June 30, 2025 | -9.289M |
| March 31, 2025 | -10.81M |
| December 31, 2024 | -8.802M |
| September 30, 2024 | -12.11M |
| June 30, 2024 | -10.38M |
| March 31, 2024 | -7.666M |
| December 31, 2023 | -11.27M |
| Date | Value |
|---|---|
| September 30, 2023 | -5.649M |
| June 30, 2023 | -7.729M |
| March 31, 2023 | -10.94M |
| December 31, 2022 | -16.59M |
| September 30, 2022 | -0.441M |
| June 30, 2022 | 0.334M |
| March 31, 2022 | -5.763M |
| December 31, 2021 | -4.091M |
| September 30, 2021 | -1.837M |
| June 30, 2021 | -2.125M |
| March 31, 2021 | -1.149M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Avadel Pharmaceuticals Plc | 0.02M |
| Jazz Pharmaceuticals Plc | 192.80M |
| Cosmo NV | -- |
| AstraZeneca PLC | 3.076B |
| GSK Plc | 742.26M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 15.15M |
| EPS Diluted (Quarterly) | -0.2276 |
| Enterprise Value | 878.08M |
| Earnings Yield | -5.46% |
| Normalized Earnings Yield | -5.972 |